Orsolya Leidecker
Impact in
- Physiology top 2%
- Calcium signaling and nucleotide metabolism
- Oncology top 5%
- PARP inhibition in cancer therapy
Papers in
- Oncology 6
- PARP inhibition in cancer therapy 4
- Peptidase Inhibition and Analysis 2
-
- Toxin Mechanisms and Immunotoxins 5
- Co-authors
- Ivan Matić (6 shared papers)Ivan Ahel (5 shared papers)Luca Palazzo (4 shared papers)Helen Dauben (2 shared papers)Thomas Colby (3 shared papers)Evgeniia A. Prokhorova (2 shared papers)Roko Žaja (2 shared papers)Juán José Bonfiglio (2 shared papers)
- Journals
- Journal of Cell Science (1 paper)Nature Chemical Biology (1 paper)Cell Cycle (1 paper)Biochemical Journal (1 paper)eLife (1 paper)
- Partner nations
- United KingdomGermanyFrance
In The Last Decade
Orsolya Leidecker
12 papers receiving 905 citations
Peers
Comparison fields: 5 of 61
- Physiology 181
- Oncology 605
- Geriatrics and Gerontology 50
- Immunology 243
- Molecular Biology 566
Countries citing papers authored by Orsolya Leidecker
This map shows the geographic impact of Orsolya Leidecker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Orsolya Leidecker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Orsolya Leidecker more than expected).
Fields of papers citing papers by Orsolya Leidecker
This network shows the impact of papers produced by Orsolya Leidecker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Orsolya Leidecker. The network helps show where Orsolya Leidecker may publish in the future.
Co-authors
The 25 scholars most cited alongside Orsolya Leidecker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 201 | |
| 2 | 2018 | 198 | |
| 3 | 2015 | 119 | |
| 4 | 2012 | 108 | |
| 5 | 2020 | 81 | |
| 6 | 2015 | 80 | |
| 7 | 2019 | 43 | |
| 8 | 2014 | 42 | |
| 9 | 2020 | 28 | |
| 10 | 2022 | 11 | |
| 11 | 2012 | 6 | |
| 12 | 2023 | 3 | |
| 13 | 2026 | 0 |
About Orsolya Leidecker
Orsolya Leidecker is a scholar working on Oncology, Immunology, Geriatrics and Gerontology, Physiology and Molecular Biology, having authored 13 papers that have together received 920 indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (6 papers), Toxin Mechanisms and Immunotoxins (5 papers), PARP inhibition in cancer therapy (4 papers), Calcium signaling and nucleotide metabolism (2 papers), Sirtuins and Resveratrol in Medicine (2 papers), RNA and protein synthesis mechanisms (2 papers), Peptidase Inhibition and Analysis (2 papers) and RNA modifications and cancer (1 paper). The work is most often cited by research in Physiology (181 citations), Oncology (605 citations), Geriatrics and Gerontology (50 citations), Immunology (243 citations) and Molecular Biology (566 citations). Orsolya Leidecker has collaborated with scholars based in United Kingdom, Germany and France. Frequent co-authors include Ivan Matić, Ivan Ahel, Luca Palazzo, Helen Dauben, Thomas Colby, Evgeniia A. Prokhorova, Roko Žaja, Juán José Bonfiglio, Dimitris P. Xirodimas and Bidesh Mahata. Their work appears in journals such as Journal of Cell Science, Nature Chemical Biology, Cell Cycle, Biochemical Journal and eLife.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.